119 related articles for article (PubMed ID: 16467680)
1. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal drug delivery system of all-trans retinoic acid.
Dong X; Chen N; Xie L; Wang S
Retina; 2006 Feb; 26(2):210-3. PubMed ID: 16467680
[TBL] [Abstract][Full Text] [Related]
2. [Antiproliferative effect of sustained drug delivery system of all-trans retinoic acid implant into rabbit's vitreous cavity for treatment of proliferative vitreoretinopathy].
Yan XR; Dong XG; Chen N; Wang W
Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):621-5. PubMed ID: 14766078
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy.
Nakagawa M; Refojo MF; Marin JF; Doi M; Tolentino FI
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2388-95. PubMed ID: 7591628
[TBL] [Abstract][Full Text] [Related]
4. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
[TBL] [Abstract][Full Text] [Related]
5. Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy.
Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
Curr Eye Res; 1995 Jun; 14(6):473-7. PubMed ID: 7671629
[TBL] [Abstract][Full Text] [Related]
6. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ogura Y
Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):672-8. PubMed ID: 12192462
[TBL] [Abstract][Full Text] [Related]
7. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR.
Giordano GG; Refojo MF; Arroyo MH
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2743-51. PubMed ID: 8344796
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis.
Dong X; Shi W; Yuan G; Xie L; Wang S; Lin P
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):492-7. PubMed ID: 16163496
[TBL] [Abstract][Full Text] [Related]
9. 13-cis-retinoic acid in silicone-fluorosilicone copolymer oil in a rabbit model of proliferative vitreoretinopathy.
Veloso AA; Kadrmas EF; Larrosa JM; Sandberg MA; Tolentino FI; Refojo MF
Exp Eye Res; 1997 Sep; 65(3):425-34. PubMed ID: 9299179
[TBL] [Abstract][Full Text] [Related]
10. Intravitreally implantable voriconazole delivery system for experimental fungal endophthalmitis.
Yang L; Dong X; Wu X; Xie L; Min X
Retina; 2011 Oct; 31(9):1791-800. PubMed ID: 21606889
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.
De Paiva MRB; Lage NA; Guerra MCA; Mol MPG; Ribeiro MCS; Fulgêncio GO; Gomes DA; Da Costa César I; Fialho SL; Silva-Cunha A
Doc Ophthalmol; 2019 Feb; 138(1):3-19. PubMed ID: 30456454
[TBL] [Abstract][Full Text] [Related]
12. [A pharmacodynamics study of an intravitreal amphotericin B drug delivery system for the treatment of experimental Aspergillus fumigatus endophthalmitis].
Yang X; Dong XG; Liu AM; Sun SY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):546-53. PubMed ID: 17897534
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes.
Theng JT; Ti SE; Zhou L; Lam KW; Chee SP; Tan D
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4895-9. PubMed ID: 14578414
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy.
Araiz JJ; Refojo MF; Arroyo MH; Leong FL; Albert DM; Tolentino FI
Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):522-30. PubMed ID: 8449673
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of a novel biodegradable long-acting intravitreal implant containing ligustrazine for the treatment of proliferative vitreoretinopathy.
Zhang X; Wei J; Ma P; Mu H; Wang A; Zhang L; Wu Z; Sun K
J Pharm Pharmacol; 2015 Feb; 67(2):160-9. PubMed ID: 25557298
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
Berger AS; Cheng CK; Pearson PA; Ashton P; Crooks PA; Cynkowski T; Cynkowska G; Jaffe GJ
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2318-25. PubMed ID: 8843916
[TBL] [Abstract][Full Text] [Related]
17. The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy.
Tahara YR; Sakamoto TR; Oshima YR; Ishibashi TR; Inomata HR; Murata TR; Hinton DR; Ryan SJ
Curr Eye Res; 1999 Oct; 19(4):323-9. PubMed ID: 10520228
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable scleral plugs for vitreoretinal drug delivery.
Yasukawa T; Kimura H; Tabata Y; Ogura Y
Adv Drug Deliv Rev; 2001 Oct; 52(1):25-36. PubMed ID: 11672873
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits.
Yu HG; Chung H
Korean J Ophthalmol; 1997 Dec; 11(2):98-105. PubMed ID: 9510652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
